Second, we will discuss the role of TTF-1 immunostaining as a prognostic marker of PFS and OS in chemotherapy for nonsq NSCLC, although the number of reports on its association with the response to PEM has increased in recent years. Here, TTF1 is linked to non-small cell lung carcinoma.